# Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols

> **NCT00968084** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 587 (actual)

## Conditions studied

- Inflammatory Disease
- Autoimmune Disease
- Immunologic Disease
- Healthy Volunteers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00968084
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-06
- **Primary completion:** —
- **Final completion:** 2017-10-25
- **Target enrollment:** 587 (ACTUAL)
- **Last updated:** 2017-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968084, "Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00968084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*